(Q43461248)

English

Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients

scientific article published in July 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

based on heuristic

inferred from title

José Antonio Pérez-Molina

object named as

José A Pérez-Molina

1

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

279-286

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Efavirenz: shifting the HAART paradigm in adult HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

The tolerability of efavirenz after nevirapine-related adverse events

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz

1 reference

https://api.crossref.org/works/10.1310%2F3Q91-YT2D-BUT4-8HN6

21 January 2018

Identifiers

10.1310/3Q91-YT2D-BUT4-8HN6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43461248&oldid=1989215113"